The role of bacteria in urinary stones formation;Udział drobnoustrojów w powstawaniu kamieni moczowych

Postepy Mikrobiologii

Volumn 42, Issue 1, 2003, Pages 39-53

  Torzewska, Agnieszka ^a  

^a UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; AMMONIUM MAGNESIUM PHOSPHATE; CALCIUM OXALATE; CALCIUM PHOSPHATE; CARBONIC ACID; CYSTINE; NANOPARTICLE; PURINE; STRUVITE; UREASE;

BACTERIAL CELL WALL; BACTERIAL FLORA; BACTERIAL INFECTION; CRYSTALLIZATION; ENVIRONMENTAL FACTOR; GLYCOCALYX; HUMAN; HYDROLYSIS; REVIEW; SPECIES DIFFERENTIATION; STONE FORMATION; URINE PH; UROLITHIASIS;

BACTERIA (MICROORGANISMS);

EID: 0141918611     PISSN: 00794252     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Bihl G., Meyers A.: Recurrent renal stone disease - advances in pathogenesis and clinical managment. Lancet, 358, 651-656 (2001)
2. Bjorklund M., Ciftcioglu N., Kajander E.O.: Extraordinary surival of nanobacteria under extreme conditions. Proc. SPIE Int. Soc. Opt. Eng. 3441, 123-129 (1998)
3. Bradbury J.: Nanobacteria may lie at the heart of kidney stones. Lancet, 352, 121 (1998)
4. Burne R.A., Chen Y-Y.M.: Bacterial ureases in infectious diseases. Microbes Infect. 2, 533-542 (2000)
5. Ciftcioglu N., Bjorklund M., Kuorikoski K., Bergstrom K., Kajander E.O.: Nanobacteria: an infectious cause for kidney stone formation. Kidney Int. 56, 1893-1898 (1999)
6. Ciftcioglu N., Kajander E.O.: Interaction of nanobacteria with cultured mammalian cells. Pathophysiology, 4, 259-270 (1998)
7. Ciftcioglu N., Kuronen I., Akerman K., Hiltunen E., Laukkanen J., Kajander E.O.: A new potential threat in antigen and antibody products: nanobacteria. (w:) Vaccines 97, red. F. Brown, D. Burton, P. Doherty, J. Mekalanos, E. Norrby, Cold Spring Harbor Laboratory Press, New York, 1997, s. 99
8. Cisar J.O., Xu D-Q., Thompson J., Swain W., Hu L., Kopecko D.J.: An alternative interpretation of nanobacteria-induced biomineralization. Proc. Natl. Acad. Sci. USA, 97, 11511-11515 (2000)
9. Clapham L., McLean R.J.C., Nickel J.C., Downey J., Costerton J.W.: The influence of bacteria on struvite crystal habit and its importance in urinary stone formation. J. Crystal Growth, 104, 475-484 (1990)
10. Coker Ch., Poore C.A., Li X., Mobley H.L.T.: Pathogenesis of Proteus mirabilis urinary tract infection. Microbes Infect. 2, 1497-1505 (2000)
11. Delatte L.C., Cifuentes J.M., Medina J.A.: Randall and his plaque. Urology, 48, 343-346 (1996)
12. Downey J.A., Nickel J.C., Clapham L., McLean R.J.C.: In vitro inhibition of struvite crystal growth by acetohydroxamic acid. Br. J. Urol. 70, 355-359 (1992)
13. Dumanski A.J., Hedelin H., Edin-Liljegren A., Beauchemin D., McLean R.J.C.: Unique ability of the Proteus mirabilis capsule to enhance mineral growth in infectious urinary calculi. Infect. Immun. 62, 2998-3003 (1994)
14. Edin-Liljegren A., Grenabo L., Hedelin H., Pettersson S., Wang Y.-H.: Long-term studies of urease-induced crystallization in human urine. J. Urol. 152, 208-212 (1994)
15. Fowler J.E.: Bacteriology of branched renal calculi and accompanying urinary tract infection. J. Urol. 131, 213-215 (1984)
16. Gleeson M.J., Griffith D.P.: Struvite calculi. Br. J. Urol. 71, 503-511 (1993)
17. Grases F., Costa-Bauza A., Garcia-Ferragut L.: Biopathological crystallization: a general view about the mechanisms of renal stone formation. Adv. Colloid Interface Sci. 74, 169-194 (1998)
18. Griffith D.P., Musher D.M, Itin C.: Urease, the primary cause of infection-induced urinary stones. Invest. Urol. 13, 346-350 (1976)
19. Griffith D.P.: Struvite stones. Kidney Int. 13, 372-382 (1978)
20. Hedelin H., Grenabo L., Pettersson S.: The effects on urease in undiluted human urine. J. Urol. 136, 743-745 (1986)
21. Hjelle J.T., Miller-Hjelle M.A., Poxton I.R., Kajander E.O., Ciftcioglu N., Jones M.L., Caughy R.C., Brown R., Millikin P.D., Darras F.S.: Endotoxin and nanobacteria in polycystic kidney disease. Kidney Int. 57, 2360-2374 (2000)
22. Hryniewicz W., Grzesiowski P., Meszaros J., Radzikowski A., Ozorowski T.: Zakażenia układu moczowego: etiologia, rozpoznawanie, leczenie. Fundacja Centrum Mikrobiologii Klinicznej Warszawa, 1999
23. Hugosson J., Grenabo L., Hedelin H., Pettersson S., Tarfusser I.: How variations in the composition of urine influence urease-induced crystallization. Urol. Res. 18, 413-417 (1990)
24. Hugosson J., Grenabo L., Hedelin H., Pettersson S., Tarfusser I.: Effects of serum, albumin and immunoglobulins on urease-induced cystallization in urine. Urol. Res. 18, 407-412 (1990)
25. Huland H., Busch R.: Chronic pyelonephritis as a cause of end-stage renal disease. J. Urol. 127, 642-643 (1982)
26. Johnson D.E., Russell R.G., Lockatell C.V., Zulty J.C., Warren J.W., Mobley H.L.T.: Contribution of Proteus mirabilis urease to persistence, urolithiasis and acute pyelonephritis in a mouse model of ascending urinary tract infection. Infect. Immun. 61, 2748-2754 (1993)
27. Jones B.D., Lockatell C.V., Johnson D.E., Warren J.W., Mobley H.L.T.: Construction of a urease-negative mutant of Proteus mirabilis: analysis of virulence in a mouse model of ascending urinary tract infection. Infect. Immun. 58, 1120-1123 (1990)
28. Kajander E.O., Bjorklund M., Ciftcioglu N.: Mineralization by nanobacteria. Proc. SPIE Int. Soc. Opt. Eng. 3441, 86-94 (1998)
29. Kajander E.O., Ciftcioglu N., Miller-Hjelle M.A., Hjelle T.: Nanobacteria: controversial pathogens in nephrolithiasis and polycystic kidney disease. Curr. Opin. Nephrol. Hy. 10, 445-452 (2001)
30. Kajander E.O., Ciftcioglu N.: Nanobacteria as extremophiles. Proc. SPIE Int. Soc. Opt. Eng. 3755, 106-112 (2000)
31. Kajander E.O., Ciftcioglu N.: Nanobacteria: an alternative mechanism for pathogenic intra- and extracellular calcification and stone formation. Proc. Natl. Acad. Sci. USA, 95, 8274-8279 (1998)
32. Kajander E.O., Kuronen I., Akerman K., Pelttari A., Ciftcioglu N.: Nanobacteria from blood, the smallest culturable autonomously replicating agent on Earth. Proc. SPIE Int. Soc. Opt. Eng. 3111, 420-428 (1997)
33. Kramer G., Klinger C.H., Steiner G.E.: Role of bacteria in the development of kidney stones. Curr. Opin. Urol. 10, 35-38 (2000)
34. Lerner S.P., Gleeson M.J., Griffith D.P.: Infection stones. J. Urol. 141, 753-758 (1989)
35. Li X., Zhao H., Lockatell C.V., Drachenberg C.B., Johnson D.E., Mobley H.L.T.: Visualization of Proteus mirabilis within the matrix of urease-induced bladder stones during experimental urinary tract infection. Infect. Immun. 70, 389-394 (2002)
36. Ling G.V., Ruby A.L., Johnson D.L., Thurmond M., Franti C.E.: Renal calculi in dogs and cats: prevalence, mineral type, breed, age, and gender interrelationships (1981-1993). J. Vet. Inter. Med. 12, 11-21 (1998)
37. McLean R.J.C., Beveridge T.J.: Metal binding capacity of bacterial surface and their ability to form mineralized aggregates. (w:) Microbial mineral recovery, red. H.L. Ehrlich C.L. Brierley, McGraw-Hill, New York, 1990, s. 185-222
38. McLean R.J.C., Downey J., Clapham L., Nickel J.C.: Influence of chondroitin sulfate, heparin sulfate, and citrate on Proteus mirabilis-induced struvite crystallization in vitro. J. Urol. 144, 1267-1271 (1990)
39. McLean R.J.C., Downey J., Clapham L., Wilson J.W.L., Nickel J.C.: Pyrophosphate inhibition of Proteus mirabilis-induced struvite crystallization in vitro. Clin. Chim. Acta. 200, 107-118 (1991)
40. McLean R.J.C., Fortin D., Brown D.A.: Microbial metal-binding mechanisms and their relation to nuclear waste disposal. Can. J. Microbiol. 42, 392-400 (1996)
41. McLean R.J.C., Lawrence J.R., Korber D.R., Caldwell D.E.: Proteus mirabilis biofilm protection against struvite crystal dissolution and its implications in struvite urolithiasis. J. Urol. 146, 1138-1142 (1991)
42. McLean R.J.C., Nickel J.C., Beveridge T.J., Costerton J.W.: Observations of the ultrastructure of infected kidney stones. J. Med. Microbiol. 29, 1-7 (1989)
43. McLean R.J.C., Nickel J.C., Cheng K.-J., Costerton J.W.: The ecology and pathogenicity of urease-producing bacteria in the urinary tract. CRC Crit. Rev. Microbiol. 16, 37-79 (1988)
44. McLean R.J.C., Nickel J.C., Noakes V.C., Costerton J.W.: An in vitro ultrastructural study of infectious kidney stone genesis. Infect. Immun. 49, 805-811 (1985)
45. Mobley H.L.T., Chippendale G.R., Swihart K., Welch R.: Cytotoxity of the HpmA and urease of Proteus mirabilis and Proteus vulgaris against cultured human renal proximal tubular cells. Infect. Immun. 59, 2036-2042 (1991)
46. Mobley H.L.T., Island M.D., Hausinger R.P.: Molecular biology of microbial ureases. Microbiol. Rev. 59, 451-480 (1995)
47. Morris N.S., Stickler D.J.: Encrustation of indwelling urethral catheters by Proteus mirabilis biofilms growing in human urine. J. Hosp. Infect. 39, 227-234 (1998)
48. Morris N.S., Stickler D.J.: The effect of urease inhibitors on the encrustation of urethral catheters. Urol. Res. 26, 275-279 (1998)
49. Moxon E.R., Kroll J.S.: The role of bacterial polysaccharide capsules as virulence factors. Curr. Top. Microbiol. Immunol. 150, 65-85 (1990)
50. Nickel J.C., Downey J.A., Costerton J.W.: Ultrastructural study of microbiologic colonization of urinary catheters. Urology, 34, 284-291 (1989)
51. Nickel J.C., Emtage J., Costerton J.W.: Ultrastructural microbial ecology of infection-induced urinary stones. J. Urol. 133, 622-627 (1985)
52. Nickel J.C., Olson M., McLean R.J.C., Grant S.K., Costerton J.W.: An ecological study of infected urinary stone genesis in an animal model. Br. J. Urol. 59, 21-30 (1987)
53. Nickel J.C., Reid G., Bruce A.W., Costerton J.W.: Ultrastructural microbiology of infected urinary stones. Urology, 28, 512-515 (1986)
54. Orłowski Z.: Kamica nerkowa. (w:) Choroby nerek, red. T. Orłowski, PZWL Warszawa, 1983, s. 386-394
55. Rodman J.S.: Struvite stones. Nephron, 81, 50-59 (1999)
56. Rose G.A.: Infection stones. (w:) Urinary stones:clinical and laboratory aspects, red. G.A. Rose, University Park Press, Baltimore, 1982, s. 257-266
57. Ryall R.L., Hibberd C.M., Mazzachi B.C., Marshall V.R.: Inhibitory activity of whole urine: comparison of urines from stone formers and healthy subjects. Clin. Chim. Acta. 154, 59-68 (1986)
58. Stickler D., Hughes G.: Ability of Proteus mirabilis to swarm over urethral catheters. Eur. J. Clin. Microbiol. Infect. Dis. 18, 206-208 (1999)
59. Stolarczyk J., Lorenz J., Otrȩba L., Dembowski J.: Zakażenie drobnoustrojami rozkładaja̧cymi mocznik w kamicy nerkowej. Urologia Polska, 34, 47-50 (1981)
60. Takasaki E., Suzuki T., Honda M., Imai T., Maeda S., Hosoya Y.: Chemical composition of 300 lower tract calculi and associated disorders in the urinary tract. Urol. Res. 54, 89-94 (1995)
61. Thomas V., Collins C.: Identification of UreR binding sites in the Enterobacteriaceae plasmid-encoded and Proteus mirabilis ureases gene operons. Mol. Microbiol. 31, 1417-1428 (1999)
62. Torzewska A.: Polisacharydy O-swoiste Proteus vulgaris -swoistość serologiczna i znaczenie w powstawaniu kamieni moczowych, Praca doktorska, Uniwersytet Łódzki Lódź 2001
63. Wainwright M.: Nanobacteria and associated "elementary bodies" in human disease and cancer. Microbiology, 145, 2623-2624 (1999)
64. Zieliński J., Kokot F., Borkowski A., Leńko J.: Kamica moczowa. (w:) Urologia, Urologia kliniczna, red. J. Zieliński, J. Leńko PZWL Warszawa, 1995, s. 280-322